Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors

Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors

Show other versions (1)

The aim of this study was to determine risk factors for adverse events (AE)-related treatment discontinuation and severe anemia among patients with chronic hepatitis C virus (HCV) genotype 1 infection, treated with first-generation protease inhibitor (PI)-based therapy. We included all patients who...

Full description

Bibliographic Details
Main Authors: N. Miotto, L.C. Mendes, L.P. Zanaga, E.S.L. Goncales, M.S.K. Lazarini, M.N. Pedro, F.L. Goncales Jr., R.S.B. Stucchi, A.G. Vigani
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2016-06-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Hepatitis C treatment
Protease inhibitor
Anemia
Adverse events
Treatment interruption
Online Access:http://www.scielo.br/pdf/bjmbr/v49n7/1414-431X-bjmbr-1414-431X20165300.pdf

Internet

http://www.scielo.br/pdf/bjmbr/v49n7/1414-431X-bjmbr-1414-431X20165300.pdf

Similar Items